References
- 1. LANE, D.A., P.M. MANNUCCI, K.A. BAUER, R.M. BERTINA, N.P. BOCHKOV, V. BOULYJNKOV, et al., Inherited thrombophilia: part 1. Thrombosis and haemostasis, 1996. 76(05): p. 651–662.
- 2. BUCHHOLZ, T. and C.J. THALER, Inherited thrombophilia: impact on human reproduction. American Journal of Reproductive Immunology, 2003. 50(1): p. 20–32.
- 3. CORIU, L., R. UNGUREANU, R. TALMACI, V. USCATESCU, M. CIRSTOIU, D. CORIU, et al., Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience. Journal of medicine and life, 2014. 7(4): p. 567.
- 4. BERTINA, R.M., B.P. KOELEMAN, T. KOSTER, F.R. ROSENDAAL, R.J. DIRVEN, H. DE RONDE, et al., Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994. 369(6475): p. 64.
- 5. RIDKER, P.M., J.P. MILETICH, C.H. HENNEKENS, and J.E. BURING, Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. Jama, 1997. 277(16): p. 1305–1307.
- 6. POORT, S.R., F.R. ROSENDAAL, P.H. REITSMA, and R.M. BERTINA, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996. 88(10): p. 3698–3703.
- 7. ROSENDAAL, F., C.J.M. DOGGEN, A. ZIVELIN, V. ARRUDA, M. AIACH, D. SISCOVICK, et al., Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and haemostasis, 1998. 79(04): p. 706–708.
- 8. BARCELLONA, D., L. FENU, C. CAULI, G. PISU, and F. MARONGIU, Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thrombosis and haemostasis, 2003. 90(12): p. 1061–1064.
- 9. WILLIAMS, K.T. and K.L. SCHALINSKE, Homocysteine metabolism and its relation to health and disease. Biofactors, 2010. 36(1): p. 19–24.
- 10. DEN HEIJER, M., S. LEWINGTON, and R. CLARKE, Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. Journal of Thrombosis and Haemostasis, 2005. 3(2): p. 292–299.
- 11. HICKS, L.K., H. BERING, K.R. CARSON, J. KLEINERMAN, V. KUKRETI, A. MA, et al., The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood, 2013. 122(24): p. 3879–3883.
- 12. CONNORS, J.M., Thrombophilia testing and venous thrombosis. New England Journal of Medicine, 2017. 377(12): p. 1177–1187.
- 13. SIMIONI, P., Who should be tested for thrombophilia? Current opinion in hematology, 2006. 13(5): p. 337–343.
- 14. ANTONOV, A., Correlation between Tumor Angiogenesis, Mutation Load, Changes in the Blood Count and the Thrombogenic Risk in Patients with Essential Thrombocythaemia and Polycythaemia Vera///Корелационна зависимост между туморната ангиогенеза, мутационния товар, промените в кръвната картина, и тромбогенния риск при пациенти с есенциална тромбоцитемия и полицитемия вера. 2018, Medical University of Varna.
- 15. NIKOLOVA-VLAHOVA M., SAVOV AL., BALEVA M. AND KARAGIOZOVA ZH., Hereditary thrombophilic factors and antiphospholipid syndrome. Medicinski pregled, 2019. 55(1): p. 46–52.
- 16. BENDER ATIK, R., O.B. CHRISTIANSEN, J. ELSON, A.M. KOLTE, S. LEWIS, S. MIDDELDORP, et al., ESHRE guideline: recurrent pregnancy loss. 2018, Oxford University Press DOI: 10.1093/hropen/hoy004.
- 17. IVANOV, P.D., R.S. KOMSA-PENKOVA, E.I. KONOVA, K.S. KOVACHEVA, M.N. SIMEONOVA, and J.D. POPOV, Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagulation & Fibrinolysis, 2009. 20(2): p. 134–140.
- 18. GONÇALVES, R.O., L.R. FRAGA, W.V.B. SANTOS, A.F.L.D. CARVALHO, B.A.V. CERQUEIRA, M.A.C. SARNO, et al., Association between the thrombophilic polymorphisms MTHFR C677T, Factor V Leiden, and prothrombin G20210A and recurrent miscarriage in Brazilian women. 2016.
- 19. SERGI, C., T. AL JISHI, and M. WALKER, Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Archives of gynecology and obstetrics, 2015. 291(3): p. 671–679.
- 20. WRAMSBY, M., M. STEN-LINDER, and K. BREMME, Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertility and sterility, 2000. 74(5): p. 987–991.
- 21. COULAM, C.B., D. WALLIS, J. WEINSTEIN, D.S. DASGUPTA, and R.S. JEYENDRAN, Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. American Journal of Reproductive Immunology, 2008. 60(5): p. 426–431.
- 22. SIMONE, B., V. DE STEFANO, E. LEONCINI, J. ZACHO, I. MARTINELLI, J. EMMERICH, et al., Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. 2013, Springer.
- 23. SILAN, F., I. MOSSE, A. GONCHAR, N. SEDLYAR, A.V. KILCHEVSKY, O. YILDIZ, et al., Comparison of the thrombophilic gene polymorphisms and recurrent pregnancy loss: Results on combined gene effect of FV Leiden, FVR2, FXIII, MTHFR (A1298C and C677T), PAI-1 4G/5G and ACE I/D genes in RPL Women from Misk/Belarus and Canakkale-Sivas/Turkey. Biomedical Genetics and Genomics, 2016. 1(4): p. 87–93.
- 24. EMMERICH, J., F.R. ROSENDAAL, M. CATTANEO, M. MARGAGLIONE, V. DE STEFANO, T. CUMMING, et al., Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Thrombosis and haemostasis, 2001. 86(09): p. 809–816.
- 25. GOODMAN, C., J. HUR, C.S. GOODMAN, R.S. JEYENDRAN, and C. COULAM, Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? American Journal of Reproductive Immunology, 2009. 62(6): p. 365–370.
- 26. SAHIN, U. and M. OZCAN, The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk. The Eurasian journal of medicine, 2017. 49(1): p. 76.
- 27. KARCZEWSKI, K.J., L.C. FRANCIOLI, G. TIAO, B.B. CUMMINGS, J. ALFÖLDI, Q. WANG, et al., Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv, 2019: p. 531210.
- 28. ZARROUK, M., S. SALIM, J. ELF, A. GOTTSÄTER, and S. ACOSTA, Testing for thrombophilia in mesenteric venous thrombosis–Retrospective original study and systematic review. Best Practice & Research Clinical Gastroenterology, 2017. 31(1): p. 39–48.
- 29. HWANG, K.R., Y.M. CHOI, J.J. KIM, S.K. LEE, K.M. YANG, E.C. PAIK, et al., Methylenetetrahydrofolate reductase polymorphisms and risk of recurrent pregnancy loss: A case-control study. Journal of Korean medical science, 2017. 32(12): p. 2029–2034.
- 30. ELGARI, M.M., N.A. IBRAHIM, A.R.M. MUDDATHIR, F.M. ELTOOM, and I.M. IBRAHIM, Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sciences, 2017. 12(1): p. 162–166.
- 31. PETRILLI, C.M., L. HEIDEMANN, M. MACK, P. DURANCE, and V. CHOPRA, Inpatient inherited thrombophilia testing. 2016.
- 32. ADLER, G., E. MAHMUTBEGOVIC, A. VALJEVAC, M.A. ADLER, N. MAHMUTBEGOVIC, K. SAFRANOW, et al., Association between-675 ID, 4G/5G PAI-1 gene polymorphism and pregnancy loss: A systematic review. Acta Informatica Medica, 2018. 26(3): p. 156.
- 33. MIDDELDORP, S., Inherited thrombophilia: a double-edged sword. ASH Education Program Book, 2016. 2016(1): p. 1–9.
- 34. KUDO, M., H.L. LEE, I.A. YANG, and P.J. MASEL, Utility of thrombophilia testing in patients with venous thrombo-embolism. Journal of thoracic disease, 2016. 8(12): p. 3697.
- 35. ZÖLLER, B., O. MELANDER, P.J. SVENSSON, and G. ENGSTRÖM, Factor V Leiden paradox in a middle-aged Swedish population: A prospective study. Vascular Medicine, 2018. 23(1): p. 52–59.